4//SEC Filing
ZEIN YOUSSEF EL 4
Accession 0000899243-20-005917
CIK 0000861838other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:12 PM ET
Size
25.4 KB
Accession
0000899243-20-005917
Insider Transaction Report
Form 4
Pillar Invest Corp
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote)
Pillar Pharmaceuticals I LP
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote) - Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote)
Pillar Pharmaceuticals II, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote)
Pillar Pharmaceuticals III, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote) - Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote)
Pillar Pharmaceuticals IV, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote) - Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote)
Pillar Pharmaceuticals V LP
Director10% Owner
Transactions
- Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote)
Pillar Pharmaceuticals 6, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote)
ZEIN YOUSSEF EL
Director
Transactions
- Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote)
Pillar Partners Foundation, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote) - Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote)
Umari Abude
10% Owner
Transactions
- Sale
Common Stock
2020-01-27$1.77/sh−15,000$26,550→ 3,284,224 total(indirect: See Footnote) - Sale
Common Stock
2020-01-28$1.76/sh−12,532$22,081→ 3,271,692 total(indirect: See Footnote) - Sale
Common Stock
2020-01-29$1.76/sh−17,250$30,438→ 3,254,442 total(indirect: See Footnote)
Footnotes (6)
- [F1]Shares sold by Pillar Pharmaceuticals I, L.P. ("Pillar I"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar I and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar I. Following this transaction, Pillar I owns directly 21,100 shares of common stock of the Issuer.
- [F2]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.77. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]Shares sold by Pillar Pharmaceuticals II, L.P. ("Pillar II"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar II and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar II. Following this transaction, Pillar II owns directly 20,820 shares of common stock of the Issuer.
- [F4]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $1.76-$1.7707. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F5]Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. Following the transactions on 1/28/20 and 1/29/20, Pillar III owns directly 29,998 shares of common stock of the Issuer.
- [F6]Shares sold by Pillar Pharmaceuticals V, L.P. ("Pillar V"). Pillar Invest Corporation ("Pillar GP") disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar V and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar V. Following this transaction, Pillar V owns directly 25,000 shares of common stock of the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001193366
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:12 PM ET
- Size
- 25.4 KB